| Name | Title | Contact Details |
|---|
Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.
Citra is a health solutions company providing a one-contract, connected solution for clinical, financial and administrative requirements. Solving for the needs of providers, payers, health systems and employers in the transition to value-based care, Citra empowers clients with proven technology, population health, analytics, care management, and administrative services to strategically expand market opportunity, diversify revenue streams, and lower the cost of care and improve quality. Serving 6 of the top 7 Health Plans; 7 Fortune 500 Companies; 50+ IPAs and MSOs managing commercial, Medicare and Medicaid populations; 100+ Provider Groups, Hospitals, Universities and Integrated Delivery Networks throughout the United States and in Puerto Rico. Citra delivers technology and services resulting in more efficient operations and higher quality care. Our vision is for providers, health systems, payers, and employers to embrace the transformation of healthcare payment models using our cohesive clinical, financial and administrative solutions.ical, financial and administrative solutions.
HolaDoctor is a global leader in Hispanic Health. Founded in 1999, HolaDoctor has a long history engaging the Hispanic community on the importance of healthy lifestyles, health insurance, access to care, and early detection and aggressive management of chronic illnesses and risk factors. HolaDoctor has an unparalleled understanding of the Hispanic healthcare consumer, the Healthcare Industry and the business opportunities created by Healthcare Reform around the Hispanic market.
Endocare is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Endocare is based in Irvine, CA. You can find more information on Endocare at www.endocare.com
Monument is an online treatment platform for those looking to change their relationship with alcohol.